{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:03:27Z","timestamp":1774123407792,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,31]]},"DOI":"10.7759\/cureus.89130","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T14:08:20Z","timestamp":1753970900000},"source":"Crossref","is-referenced-by-count":1,"title":["Use of Fructosamine for Glycemic Monitoring in Patients With Sickle Cell Disease and Diabetes: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Mohammed","family":"Gaffar Mohammed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada A","family":"Alsiddig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lobna A","family":"Ibrahim Hag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-5-201109060-01003","article-title":"In the clinic. Sickle cell disease","volume":"155","author":"Steinberg MH","year":"2011","unstructured":"Steinberg MH. In the clinic. Sickle cell disease. Ann Intern Med. 2011, 155:ITC31-15. 10.7326\/0003-4819-155-5-201109060-01003","journal-title":"Ann Intern Med"},{"key":"ref2","unstructured":"World Health Organization. Sickle-cell anaemia. Report by the Secretariat. (2006). Accessed. June 17, 2022: https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA59\/A59_9-en.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/gim.0b013e318065a9e8","article-title":"Premarital screening for thalassemia and sickle cell disease in Saudi Arabia","volume":"9","author":"Alhamdan NA","year":"2007","unstructured":"Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med. 2007, 9:372-7. 10.1097\/gim.0b013e318065a9e8","journal-title":"Genet Med"},{"key":"ref4","unstructured":"Saudi Arabia. International Diabetes Federation. (2025). Accessed. Jun 27, 2025: https:\/\/idf.org\/our-network\/regions-and-members\/middle-east-and-north-africa\/members\/saudi-arabia\/."},{"key":"ref5","unstructured":"The A1C Test & Diabetes. (2018). Accessed. June 17, 2022: https:\/\/www.niddk.nih.gov\/health-information\/diagnostic-tests\/a1c-test."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-S006","article-title":"6. Glycemic targets: standards of medical care in diabetes-2018","volume":"41","year":"2018","unstructured":"6. Glycemic targets. standards of medical care in diabetes-2018. Diabetes Care. 2018, 41:S55-64. 10.2337\/dc18-S006","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"61","author":"Davies MJ","year":"2018","unstructured":"Davies MJ, D'Alessio DA, Fradkin J, et al.. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018, 61:2461-98. 10.1007\/s00125-018-4729-5","journal-title":"Diabetologia"},{"key":"ref8","unstructured":"Factors that interfere with HbA1c test results. (2024). Accessed. June 17, 2022: https:\/\/ngsp.org\/factors.asp."},{"key":"ref9","unstructured":"The A1C Test & Diabetes. (2018). Accessed. June 27, 2025: https:\/\/www.niddk.nih.gov\/health-information\/diagnostic-tests\/a1c-test?dkrd=\/health-information\/diabetes\/overview\/tes...."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.3.265","article-title":"Recent progress in glycohemoglobin (HbA1c) testing","volume":"23","author":"Little RR","year":"2000","unstructured":"Little RR. Recent progress in glycohemoglobin (HbA1c) testing. Diabetes Care. 2000, 23:265-6. 10.2337\/diacare.23.3.265","journal-title":"Diabetes Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes-2023","volume":"46","author":"ElSayed NA","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al.. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023, 46:S19-40. 10.2337\/dc23-S002","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-1-68_2","article-title":"Hemoglobinopathies affect hemoglobin A1C measurement","volume":"115","author":"Holt GS","year":"1991","unstructured":"Holt GS, Wofford JL, Velez R. Hemoglobinopathies affect hemoglobin A1C measurement. Ann Intern Med. 1991, 115:68-9. 10.7326\/0003-4819-115-1-68_2","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2012.110717","article-title":"Advantage of HbA1c assay by HPLC D-10 versus cobas integra 400 in a population carrier for HbS and HbC","volume":"58","author":"Bouzid K","year":"2012","unstructured":"Bouzid K, Bahlous A, Ferjani W, Kalai E, Ducrocq R, Mami FB, Abdelmoula J. Advantage of HbA1c assay by HPLC D-10 versus cobas integra 400 in a population carrier for HbS and HbC. Clin Lab. 2012, 58:821-8. 10.7754\/Clin.Lab.2012.110717","journal-title":"Clin Lab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.09.042","article-title":"Determinants of fructosamine levels in a multi-ethnic Sub-Saharan African population","volume":"107","author":"Nouya AY","year":"2015","unstructured":"Nouya AY, Nansseu JR, Moor VJ, et al.. Determinants of fructosamine levels in a multi-ethnic Sub-Saharan African population. Diabetes Res Clin Pract. 2015, 107:123-9. 10.1016\/j.diabres.2014.09.042","journal-title":"Diabetes Res Clin Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814567227","article-title":"Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes","volume":"9","author":"Danese E","year":"2015","unstructured":"Danese E, Montagnana M, Nouvenne A, Lippi G. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes. J Diabetes Sci Technol. 2015, 9:169-76. 10.1177\/1932296814567227","journal-title":"J Diabetes Sci Technol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.1.163","article-title":"Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy","volume":"26","author":"Cohen RM","year":"2003","unstructured":"Cohen RM, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care. 2003, 26:163-7. 10.2337\/diacare.26.1.163","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108918","article-title":"Serum fructosamine and glycemic status in the presence of the sickle cell mutation","volume":"177","author":"Doumatey AP","year":"2021","unstructured":"Doumatey AP, Feron H, Ekoru K, Zhou J, Adeyemo A, Rotimi CN. Serum fructosamine and glycemic status in the presence of the sickle cell mutation. Diabetes Res Clin Pract. 2021, 177:108918. 10.1016\/j.diabres.2021.108918","journal-title":"Diabetes Res Clin Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212552","article-title":"Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait","volume":"14","author":"Skinner S","year":"2019","unstructured":"Skinner S, Diaw M, Ndour Mbaye M, et al.. Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait. PLoS One. 2019, 14:e0212552. 10.1371\/journal.pone.0212552","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.4103\/1117-1936.180490","article-title":"Serum fructosamine in the assessment of glycaemic status in patients with sickle cell anaemia","volume":"13","author":"Yahaya IA","year":"2006","unstructured":"Yahaya IA, Isah HS, Anaja PO. Serum fructosamine in the assessment of glycaemic status in patients with sickle cell anaemia. Niger Postgrad Med J. 2006, 13:95-8.","journal-title":"Niger Postgrad Med J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1360","article-title":"Racial differences in and prognostic value of biomarkers of hyperglycemia","volume":"39","author":"Parrinello CM","year":"2016","unstructured":"Parrinello CM, Sharrett AR, Maruthur NM, Bergenstal RM, Grams ME, Coresh J, Selvin E. Racial differences in and prognostic value of biomarkers of hyperglycemia. Diabetes Care. 2016, 39:589-95. 10.2337\/dc15-1360","journal-title":"Diabetes Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-154112","article-title":"Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c","volume":"112","author":"Cohen RM","year":"2008","unstructured":"Cohen RM, Franco RS, Khera PK, et al.. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood. 2008, 112:4284-91. 10.1182\/blood-2008-04-154112","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111463","article-title":"Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies-cross-sectional and longitudinal experience from the AMORIS cohort","volume":"9","author":"Malmstr\u00f6m H","year":"2014","unstructured":"Malmstr\u00f6m H, Walldius G, Grill V, Jungner I, Gudbj\u00f6rnsdottir S, Hammar N. Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies-cross-sectional and longitudinal experience from the AMORIS cohort. PLoS One. 2014, 9:e111463. 10.1371\/journal.pone.0111463","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/386771-use-of-fructosamine-for-glycemic-monitoring-in-patients-with-sickle-cell-disease-and-diabetes-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T14:08:21Z","timestamp":1753970901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/386771-use-of-fructosamine-for-glycemic-monitoring-in-patients-with-sickle-cell-disease-and-diabetes-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.89130","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}